Literature DB >> 23187725

Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists.

Takato Hiranita1, Maddalena Mereu, Paul L Soto, Gianluigi Tanda, Jonathan L Katz.   

Abstract

Sigma(1) receptors (σ(1)Rs) are intracellularly mobile chaperone proteins implicated in several disease processes, as well as psychiatric disorders and substance abuse. Here we report that although selective σ(1)R agonists (PRE-084, (+)-pentazocine) lacked reinforcing effects in drug-naive rats, over the course of 28 experimental sessions, which was more than sufficient for acquisition of cocaine self-administration, responding was not maintained by either σ(1)R agonist. In contrast, after subjects self-administered cocaine σ(1)R agonists were readily self-administered. The induced reinforcing effects were long lasting; a response for which subjects had no history of reinforcement was newly conditioned with both σ(1)R agonists, extinguished when injections were discontinued, and reconditioned when σ(1)R agonists again followed responses. Experience with food reinforcement was ineffective as an inducer of σ(1)R agonist reinforcement. Although a variety of dopamine receptor antagonists blocked cocaine self-administration, consistent with its dopaminergic mechanism, PRE-084 self-administration was entirely insensitive to these drugs. Conversely, the σR antagonist, BD1063, blocked PRE-084 self-administration but was inactive against cocaine. In microdialysis studies i.v. PRE-084 did not significantly stimulate dopamine at doses that were self-administered in rats either with or without a cocaine self-administration experience. The results indicate that cocaine experience induces reinforcing effects of previously inactive σ(1)R agonists, and that the mechanism underlying these reinforcing effects is dopamine independent. It is further suggested that induced σ(1)R mechanisms may have an essential role in treatment-resistant stimulant abuse, suggesting new approaches for the development of effective medications for stimulant abuse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187725      PMCID: PMC3572457          DOI: 10.1038/npp.2012.224

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  51 in total

1.  Pharmacotherapy and other treatments for cocaine abuse and dependence.

Authors:  Frank J Vocci; Ahmed Elkashef
Journal:  Curr Opin Psychiatry       Date:  2005-05       Impact factor: 4.741

2.  Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls.

Authors:  Roman Stefanski; Zuzana Justinova; Teruo Hayashi; Minoru Takebayashi; Steven R Goldberg; Tsung-Ping Su
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

3.  Cocaine binding at sigma receptors.

Authors:  J Sharkey; K A Glen; S Wolfe; M J Kuhar
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

4.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Protein kinase A activation down-regulates, whereas extracellular signal-regulated kinase activation up-regulates sigma-1 receptors in B-104 cells: Implication for neuroplasticity.

Authors:  Gianfrancesco Cormaci; Tomohisa Mori; Teruo Hayashi; Tsung-Ping Su
Journal:  J Pharmacol Exp Ther       Date:  2006-10-18       Impact factor: 4.030

6.  Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.

Authors:  Takato Hiranita; Paul L Soto; Stephen J Kohut; Theresa Kopajtic; Jianjing Cao; Amy H Newman; Gianluigi Tanda; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2011-08-22       Impact factor: 4.030

7.  Compensatory effect by sigma1 (sigma1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task.

Authors:  Johann Meunier; Bénédicte Demeilliers; Aurélie Célérier; Tangui Maurice
Journal:  Behav Brain Res       Date:  2005-09-26       Impact factor: 3.332

Review 8.  Medication development for addictive disorders: the state of the science.

Authors:  Frank J Vocci; Jane Acri; Ahmed Elkashef
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

Review 9.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

10.  Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.

Authors:  Takato Hiranita; Paul L Soto; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2009-02-19       Impact factor: 4.030

View more
  23 in total

1.  Role of the σRs for Development of Medications.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2013-09-12

2.  Cocaine Antagonists; Studies on Cocaine Self-Administration.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2015-09-03

3.  Identification of Antagonists Selective for Sigma Receptor Subtypes that are Active In vivo.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2016-07-11

Review 4.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

5.  The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.

Authors:  Weimin Conrad Hong; Hideaki Yano; Takato Hiranita; Frederick T Chin; Christopher R McCurdy; Tsung-Ping Su; Susan G Amara; Jonathan L Katz
Journal:  J Biol Chem       Date:  2017-05-11       Impact factor: 5.157

6.  Stimulants as specific inducers of dopamine-independent σ agonist self-administration in rats.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Theresa A Kopajtic; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2013-08-01       Impact factor: 4.030

7.  Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways.

Authors:  Jeffrey L Barr; Elena Deliu; G Cristina Brailoiu; Pingwei Zhao; Guang Yan; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Cell Calcium       Date:  2015-05-27       Impact factor: 6.817

8.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

Review 9.  A role for sigma receptors in stimulant self-administration and addiction.

Authors:  Jonathan L Katz; Weimin C Hong; Takato Hiranita; Tsung-Ping Su
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

10.  Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists.

Authors:  Jonathan L Katz; Takato Hiranita; Theresa A Kopajtic; Kenner C Rice; Christophe Mesangeau; Sanju Narayanan; Ahmed H Abdelazeem; Christopher R McCurdy
Journal:  J Pharmacol Exp Ther       Date:  2016-04-21       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.